120 related articles for article (PubMed ID: 20357255)
1. Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation.
Min L; Mohammad Isa SA; Shuai W; Piang CB; Nih FW; Kotaka M; Ruedl C
J Immunol; 2010 May; 184(9):4625-9. PubMed ID: 20357255
[TBL] [Abstract][Full Text] [Related]
2. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
[TBL] [Abstract][Full Text] [Related]
3. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
[TBL] [Abstract][Full Text] [Related]
4. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors.
Dresch C; Ackermann M; Vogt B; de Andrade Pereira B; Shortman K; Fraefel C
Eur J Immunol; 2011 Sep; 41(9):2544-55. PubMed ID: 21748731
[TBL] [Abstract][Full Text] [Related]
5. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells.
Zhan Y; Carrington EM; van Nieuwenhuijze A; Bedoui S; Seah S; Xu Y; Wang N; Mintern JD; Villadangos JA; Wicks IP; Lew AM
Eur J Immunol; 2011 Sep; 41(9):2585-95. PubMed ID: 21660938
[TBL] [Abstract][Full Text] [Related]
7. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.
Pulendran B; Dillon S; Joseph C; Curiel T; Banchereau J; Mohamadzadeh M
Eur J Immunol; 2004 Jan; 34(1):66-73. PubMed ID: 14971031
[TBL] [Abstract][Full Text] [Related]
10. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs.
Vremec D; Lieschke GJ; Dunn AR; Robb L; Metcalf D; Shortman K
Eur J Immunol; 1997 Jan; 27(1):40-4. PubMed ID: 9021996
[TBL] [Abstract][Full Text] [Related]
11. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-mediated communication between dendritic epidermal T cells and Langerhans cells. In vitro studies using cell lines.
Yokota K; Ariizumi K; Kitajima T; Bergstresser PR; Street NE; Takashima A
J Immunol; 1996 Aug; 157(4):1529-37. PubMed ID: 8759735
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
14. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
[TBL] [Abstract][Full Text] [Related]
15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
17. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
18. CD8alpha(-) and CD8alpha(+) subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo.
De Smedt T; Butz E; Smith J; Maldonado-López R; Pajak B; Moser M; Maliszewski C
J Leukoc Biol; 2001 Jun; 69(6):951-8. PubMed ID: 11404381
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species level defines two functionally distinctive stages of inflammatory dendritic cell development from mouse bone marrow.
Sheng KC; Pietersz GA; Tang CK; Ramsland PA; Apostolopoulos V
J Immunol; 2010 Mar; 184(6):2863-72. PubMed ID: 20176741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]